A detailed history of Fifth Third Bancorp transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 2,176 shares of CTKB stock, worth $14,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,176
Previous 826 163.44%
Holding current value
$14,122
Previous $4,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$4.73 - $6.73 $6,385 - $9,085
1,350 Added 163.44%
2,176 $12,000
Q2 2024

Jul 22, 2024

BUY
$5.3 - $6.91 $371 - $483
70 Added 9.26%
826 $4,000
Q4 2023

Jan 19, 2024

BUY
$4.1 - $9.51 $2,570 - $5,962
627 Added 486.05%
756 $6,000
Q3 2023

Oct 31, 2023

SELL
$5.52 - $9.5 $2,373 - $4,085
-430 Reduced 76.92%
129 $0
Q2 2023

Jul 25, 2023

BUY
$6.69 - $11.99 $3,739 - $6,702
559 New
559 $4,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $874M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.